Overview

Dr. Charles (Chuck) Meeker holds advanced degrees and training in the life sciences, including biochemistry, molecular biology, oncological sciences, and biotechnology. Clients appreciate Dr. Meeker’s deep knowledge in these areas to help them understand and navigate the unique challenges of IP prosecution in these and other fields. In the U.S. and overseas, clients rely on his experience to counsel and execute on issues related to the procurement and protection of intellectual property rights, including patents, trademarks, trade dress, trade secrets, and copyrights, as well as strategic legal and business decisions related to IP monetization, licensing, enforcement, and defense, and IP-related acquisition and due diligence.

Dr. Meeker’s work includes patents for pharmaceutical drugs and drug delivery systems, chemical compositions and systems, plant science and cell culture technology, PCR technologies and DNA melting curve analysis, fluorescence and luminescence imaging and monitoring, pathology diagnostic equipment and methods, hydrocarbon purification and treatment systems, liquid filtration materials and systems, and a variety of other products, systems, and methods. Dr. Meeker has also been instrumental in many of his clients’ successful launch, sale, and licensing of patented technologies, merger/acquisition by industry leaders, and defense and maintenance of challenged IP.

Experience

Experience
  • U.S. and International Prosecution of IP
  • U.S. and International Patent Prosecution
  • U.S. Trademark Prosecution
  • Biotechnology, Biochemical, Chemical, Pharmaceutical, and Life Sciences
  • Medical Devices, Drug Delivery Systems and Therapeutics
  • Material Sciences, Mechanics Devices and Mechanical Engineering

Education

Education
  • J.D., with honors, Indiana University Maurer School of Law, 2013
  • Ph.D., Department of Oncological Sciences, University of Utah School of Medicine, 2011
  • B.S., Biology, Brigham Young University, 2004

Admissions

Admissions
  • Utah State Bar
  • Registered Patent Attorney, U.S. Patent and Trademark Office

Community Involvement

Community Involvement
  • Editor, IP Theory, Indiana University Maurer School of Law, 2011-2012

Memberships

Memberships
  • American Intellectual Property Law Association (AIPLA)

Publications

Publications
  • Geneviève Desjardins, Charles A. Meeker, Niraja Bhachech, Simon L. Currie, Mark Okon, Barbara J. Graves, and Lawrence P. McIntosh, Synergy of aromatic residues and phosphoserines within the intrinsically disordered DNA-binding inhibitory elements of the Ets-1 transcription factor, Proc. Natl.
  • Charles A. Meeker, Mechanistic dissection of phosphorylation-dependent regulation of Ets-1 DNA binding, ProQuest, UMI Dissertation Publishing, 2012.
  • Gregory M. Lee, Miles A. Pufall, Charles A. Meeker, HanSo Kang, Barbara J. Graves, and Lawrence P. McIntosh, The affinity of Ets-1 for DNA is modulated by phosphorylation through transient interactions of an unstructured region, Journal of Molecular Biology, Vol. 382(4), pp. 1014-30, 2008.
  • New Micro-Entity Fee Reduction Now Available at the European Patent Office

    With all the focus on the new European Unitary Patent System and Unified Patent Court, a recent development at the...
    Read More
  • Paris Convention Pitfalls When Filing Follow-on Patent Applications

    The United States and most countries around the world are party to the Paris Convention for the Protection of Industrial...
    Read More
  • Now May Not be the Best Time to Enforce Your Diagnostic Method Patent

    Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC (Fed. Cir. 2019). In the wake of the Federal Circuit’s decision to...
    Read More
  • Tribal Sovereign Immunity a No-go in Allergan IPR

    The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) recently rejected the sovereign...
    Read More
  • Navigating the Patent Prosecution Highway (PPH)

    Patent Applicants often wish they could accelerate examination of their U.S. applications when corresponding patent claims have already been determined...
    Read More
  • Overcoming a Rejection for Lack of Written Description or Enablement by Making a Deposit of Biological Material

     Procedures for Deposition of a Biological Sample to Overcome a 112 Enablement Rejection  According to the Manual of Patent Examining...
    Read More

Maria Rubi

Experience

  • 1 year at Workman Nydegger

Contact Information
Email  mrubi@wnlaw.com
Phone  801-533-9800

Tyler Eller

Experience

  • 15 years at Workman Nydegger
  • Patent and Trademark Filings, U.S. and foreign
  • Management of Patent Portfolios

Education

  • B.A., English, University of Utah, 2009

Contact Information
Email  teller@wnlaw.com
Phone  801-533-9800

View his full bio here.

Languages

Languages
  • Korean